{"result": "(\"entity\"<|>SPANISH SOCIETY OF ENDOCRINOLOGY AND NUTRITION<|>ORGANIZATION<|>The Spanish Society of Endocrinology and Nutrition is a professional organization focused on the study and management of endocrine disorders, including diabetes mellitus.)\n##\n(\"entity\"<|>AMERICAN DIABETES ASSOCIATION<|>ORGANIZATION<|>The American Diabetes Association is a national organization that provides information, research, and advocacy for diabetes care and education.)\n##\n(\"entity\"<|>DIABETES MELLITUS<|>EVENT<|>Diabetes Mellitus is a chronic condition characterized by high blood sugar levels due to insulin resistance or insufficient insulin production.)\n##\n(\"entity\"<|>HYPOGLYCEMIA<|>EVENT<|>Hypoglycemia is a condition where blood sugar levels drop abnormally low, which can occur in individuals with diabetes, especially those on insulin or other hypoglycemic medications.)\n##\n(\"entity\"<|>MEZQUITA-RAYA P<|>PERSON<|>Mezquita-Raya P is an author associated with the position document on the evaluation and management of hypoglycemia in diabetes patients.)\n##\n(\"entity\"<|>REYES-GARCÍA R<|>PERSON<|>Reyes-García R is an author contributing to the position document on hypoglycemia management in diabetes patients.)\n##\n(\"entity\"<|>MORENO-PÉREZ O<|>PERSON<|>Moreno-Pérez O is an author of the position document regarding hypoglycemia in diabetes management.)\n##\n(\"entity\"<|>MUÑOZ-TORRES M<|>PERSON<|>Muñoz-Torres M is an author involved in the position document on hypoglycemia management in diabetes patients.)\n##\n(\"entity\"<|>MERINO-TORRES JF<|>PERSON<|>Merino-Torres JF is an author of the position document on the evaluation and management of hypoglycemia in diabetes patients.)\n##\n(\"entity\"<|>GORGOJO-MARTÍNEZ JJ<|>PERSON<|>Gorgojo-Martínez JJ is an author contributing to the position document on hypoglycemia in diabetes management.)\n##\n(\"relationship\"<|>SPANISH SOCIETY OF ENDOCRINOLOGY AND NUTRITION<|>AMERICAN DIABETES ASSOCIATION<|>Both organizations are involved in diabetes care and management, providing guidelines and research on diabetes and hypoglycemia<|>7)\n##\n(\"relationship\"<|>HYPOGLYCEMIA<|>DIABETES MELLITUS<|>Hypoglycemia is a common complication associated with diabetes mellitus, particularly in patients undergoing treatment<|>8)\n##\n(\"relationship\"<|>MEZQUITA-RAYA P<|>SPANISH SOCIETY OF ENDOCRINOLOGY AND NUTRITION<|>Mezquita-Raya P is an author of a document published by the Spanish Society of Endocrinology and Nutrition regarding hypoglycemia management<|>6)\n##\n(\"relationship\"<|>REYES-GARCÍA R<|>SPANISH SOCIETY OF ENDOCRINOLOGY AND NUTRITION<|>Reyes-García R is an author of the position document published by the Spanish Society of Endocrinology and Nutrition<|>6)\n##\n(\"relationship\"<|>MORENO-PÉREZ O<|>SPANISH SOCIETY OF ENDOCRINOLOGY AND NUTRITION<|>Moreno-Pérez O is an author of the position document published by the Spanish Society of Endocrinology and Nutrition<|>6)\n##\n(\"relationship\"<|>MUÑOZ-TORRES M<|>SPANISH SOCIETY OF ENDOCRINOLOGY AND NUTRITION<|>Muñoz-Torres M is an author of the position document published by the Spanish Society of Endocrinology and Nutrition<|>6)\n##\n(\"relationship\"<|>MERINO-TORRES JF<|>SPANISH SOCIETY OF ENDOCRINOLOGY AND NUTRITION<|>Merino-Torres JF is an author of the position document published by the Spanish Society of Endocrinology and Nutrition<|>6)\n##\n(\"relationship\"<|>GORGOJO-MARTÍNEZ JJ<|>SPANISH SOCIETY OF ENDOCRINOLOGY AND NUTRITION<|>Gorgojo-Martínez JJ is an author of the position document published by the Spanish Society of Endocrinology and Nutrition<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 3 Complicaciones agudas\n\n### 30 En relación con las alteraciones hipoglucémicas, señale la afirmación falsa:\n\nA. La primera defensa fisiológica contra la hipoglucemia en el individuo sano es el aumento de glucagón.\nB. La causa más frecuente de hipoglucemias son los fármacos.\nC. En la hipoglucemia autoinmunitaria, los niveles de insulina circulantes se encuentran característicamente elevados.\nD. La hipoglucemia asociada con fallo autonómico puede predisponer a la aparición de arritmias cardíacas en pacientes con diabetes.\n\n### COMENTARIO\n\nCuando la glucemia plasmática comienza a disminuir, el primer mecanismo en ponerse en marcha es el descenso en la secreción de insulina, lo que ocasiona un incremento en la secreción hepática y renal de glucosa y un descenso en la utilización de esta en tejidos periféricos. Como segundo paso, se activa la producción de glucagón y noradrenalina, que estimulan la glucogenólisis y la neoglucogénesis hepática.\n\nLa causa más frecuente de hipoglucemia son los fármacos (insulina e hipoglucemiantes orales). La hipoglucemia por hiperinsulinismo endógeno tiene su origen principal en los tumores pancreáticos y extrapancreáticos. En los últimos años se ha descrito un aumento de las causas autoinmunitarias, cuya etiología reconoce la presencia de anticuerpos específicos dirigidos contra la insulina, su receptor, e incluso la propia célula β. Son producidos en el curso de otras enfermedades autoinmunitarias y están relacionados con estas y/o con fármacos empleados en su tratamiento (destacando aquellos que contienen el grupo sulfhidrilo), que alterarían de algún modo la molécula de insulina confiriéndole mayor inmunogenicidad y disminuyendo, a la vez, su actividad biológica.\n\nLa hipoglucemia asociada con fallo autonómico puede predisponer a la aparición de arritmias cardíacas en pacientes con diabetes. La mayor evidencia procede de estudios con hipoglucemia experimental, en los que la hipoglucemia induce cambios en la repolarización y arritmias tanto en DM1 como en DM2.\n\nReferencias:\n- Mezquita-Raya P, Reyes-García R, Moreno-Pérez O, Muñoz-Torres M, Merino-Torres JF, Gorgojo-Martínez JJ, et al. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition (SEEN). Documento de posicionamiento: evaluación y manejo de la hipoglucemia en el paciente con diabetes mellitus. Endocrinol Nutr. 2013;60(9):517.e1-18.\n- Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384-95.\n- Taylor SI, Barbetti F, Accili D, Roth J, Gorden G. Syndromes of autoimmunity and hypoglycemia. Endocrinol Metab Clin North Am. 1989;18:123-43.\n---\n## 31. Actualmente, tanto a nivel internacional (Workgroup of the American Diabetes Association and The Endocrine Society) como nacional (Grupo de Trabajo de Diabetes Mellitus de la Sociedad Española de Endocrinología y Nutrición), el punto de corte para considerar en riesgo de hipoglucemia a un paciente diabético en tratamiento con hipoglucemiantes se ha establecido:\n\nA. En menor o igual a 45 mg/dl.\nB. En menor o igual a 50 mg/dl.\nC. En menor o igual a 60 mg/dl.\nD. En menor o igual a 70 mg/dl.\n\n### COMENTARIO\n\nLa hipoglucemia es el principal factor limitante en el manejo glucémico de la DM1 y la DM2. En pacientes con diabetes, la hipoglucemia se define como cualquier episodio de concentración plasmática de glucosa anormalmente baja (con o sin síntomas) en el que el individuo se expone a un daño. El valor por debajo del cual se define la hipoglucemia en pacientes con diabetes, 70 mg/dl, es más alto que el empleado para diagnosticar la hipoglucemia en pacientes no diabéticos (menor de 55 mg/dl), y no está exento de debate. Se define tomando como base el umbral glucémico normal para la secreción hormonal contrarreguladora. Debido a que muchas personas con diabetes muestran respuestas contrarreguladoras deficientes a la hipoglucemia y/o experimentan falta de conciencia de hipoglucemia, una medición de glucosa con un nivel inferior a 70 mg/dl (3,9 mmol/l) se considera clínicamente importante, independientemente de la gravedad de los síntomas de hipoglucemia aguda\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}